Therefore, this study aimed to systematically assess the efficacy of M. charantia compared with placebo or active controls on FBG, HbA1c, insulin, homeostatic model of insulin resistance (HOMA-IR) and HOMA-β in adults with prediabetes or type 2 diabetes. The gene discussed is INS; the disease is prediabetes syndrome.